−2.69 CNY
−1.05 B CNY
124.04 M CNY
305.76 M
About MABWELL (SHANGHAI) BIOSCIENCE
Sector
Industry
CEO
Da Tao Liu
Website
Headquarters
Shanghai
Founded
2017
ISIN
CNE100005RD2
FIGI
BBG00YLZ63R2
Mabwell (Shanghai) Bioscience Co., Ltd. engages in the research and development, production and sales of therapeutic biological products. Its main product is antibody drugs. Its platform covered antibody drug discovery, pharmaceutical development, quality research control and assurance, medical and clinical operations, and commercial base. The company was founded on May 12, 2017 and is headquartered in Shanghai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 688062 is 20.67 CNY — it has decreased by −0.94% in the past 24 hours. Watch MABWELL (SHANGHAI) BIOSCIENCE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange MABWELL (SHANGHAI) BIOSCIENCE stocks are traded under the ticker 688062.
688062 stock has risen by 0.96% compared to the previous week, the month change is a −11.02% fall, over the last year MABWELL (SHANGHAI) BIOSCIENCE has showed a −35.08% decrease.
688062 reached its all-time high on Mar 14, 2024 with the price of 37.00 CNY, and its all-time low was 12.96 CNY and was reached on Oct 11, 2022. View more price dynamics on 688062 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
688062 stock is 3.59% volatile and has beta coefficient of 1.41. Track MABWELL (SHANGHAI) BIOSCIENCE stock price on the chart and check out the list of the most volatile stocks — is MABWELL (SHANGHAI) BIOSCIENCE there?
Today MABWELL (SHANGHAI) BIOSCIENCE has the market capitalization of 8.47 B, it has increased by 1.53% over the last week.
Yes, you can track MABWELL (SHANGHAI) BIOSCIENCE financials in yearly and quarterly reports right on TradingView.
688062 net income for the last quarter is −249.11 M CNY, while the quarter before that showed −239.32 M CNY of net income which accounts for −4.09% change. Track more MABWELL (SHANGHAI) BIOSCIENCE financial stats to get the full picture.
No, 688062 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 1.49 K employees. See our rating of the largest employees — is MABWELL (SHANGHAI) BIOSCIENCE on this list?
Like other stocks, 688062 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MABWELL (SHANGHAI) BIOSCIENCE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MABWELL (SHANGHAI) BIOSCIENCE technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MABWELL (SHANGHAI) BIOSCIENCE stock shows the strong sell signal. See more of MABWELL (SHANGHAI) BIOSCIENCE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.